| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/08/2023 | Merus N.V. | MRUS | Grant | Share option (right to buy) | 14.4k | $23.29 | $335.7k | | 06/08/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Disposition | Stock Option (right to buy) | 420 | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Disposition | Stock Option (right to buy) | 800 | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Grant | Common Stock | 1.7k | $0.00 | $0 | | 05/31/2023 |
| 05/31/2023 | Kala Pharmaceuticals, Inc. | KALA | Disposition | Stock Option (right to buy) | 518 | $0.00 | $0 | | 05/31/2023 |
| 06/16/2022 | Kala Pharmaceuticals, Inc. | KALA | Grant | Stock Option (right to buy) | 40k | $0.36 | $14.4k | | 06/16/2022 |
| 05/31/2022 | Merus N.V. | MRUS | Grant | Share option (right to buy) | 16.6k | $18.56 | $308.2k | | 05/31/2022 |
| 02/25/2022 | Finch Therapeutics Group, Inc. | FNCH | Grant | Employee Stock Option (right to buy) | 80k | $8.61 | $688.8k | | 02/25/2022 |
| 06/17/2021 | Kala Pharmaceuticals, Inc. | KALA | Grant | | 20k | $0.00 | $0 | | 06/17/2021 |
| 05/28/2021 | Merus N.V. | MRUS | Grant | Share option (right to buy) | 6.1k | $21.15 | $129.4k | | 05/28/2021 |
| 03/18/2021 | Finch Therapeutics Group, Inc. | FNCH | Grant | Employee Stock Option (right to buy) | 55.4k | $17.00 | $941.6k | | 03/18/2021 |
| 06/30/2020 | Merus N.V. | MRUS | Grant | Share Option (right to buy) | 8.6k | $16.09 | $138.9k | | 06/30/2020 |
| 06/25/2020 | Kala Pharmaceuticals, Inc. | KALA | Grant | | 20k | $0.00 | $0 | | 06/25/2020 |
| 06/05/2019 | Kala Pharmaceuticals, Inc. | KALA | Grant | Stock Option (right to buy) | 21k | $5.35 | $112.4k | | 06/05/2019 |
| 02/28/2018 | Kala Pharmaceuticals, Inc. | KALA | Grant | Stock Option (right to buy) | 25.9k | $14.05 | $364.2k | | 02/28/2018 |
| 05/09/2017 | NOVELION THERAPEUTICS INC. | NVLNF | Exercise | Restricted Stock Units | 2.4k | $0.00 | $0 | | 05/09/2017 |
| 05/09/2017 | NOVELION THERAPEUTICS INC. | NVLNF | Payment of Exercise | Common Shares | 710 | $9.42 | $6.7k | | 05/09/2017 |
| 12/22/2016 | NOVELION THERAPEUTICS INC. | NVLNF | Grant | Stock Option (right to buy) | 166k | $0.00 | $0 | | 12/22/2016 |
| 02/26/2015 | Carisma Therapeutics Inc. | SESN | Grant | Stock Option | 57.5k | $10.39 | $597.4k | | 02/26/2015 |
| 01/02/2015 | Ocata Therapeutics, Inc. | OCAT | Grant | Stock Option (Right to Buy) | 5k | $6.39 | $32k | | 01/02/2015 |
| 12/31/2014 | Ocata Therapeutics, Inc. | OCAT | Grant | Common Stock | 1.2k | $0.00 | $0 | | 12/31/2014 |
| 09/30/2014 | Ocata Therapeutics, Inc. | OCAT | Grant | Common Stock | 1.2k | $0.00 | $0 | | 09/30/2014 |
| 06/30/2014 | Ocata Therapeutics, Inc. | OCAT | Grant | Common Stock | 125k | $0.00 | $0 | | 06/30/2014 |
| 03/31/2014 | Ocata Therapeutics, Inc. | OCAT | Grant | Common Stock | 125k | $0.00 | $0 | | 03/31/2014 |
| 01/02/2014 | Ocata Therapeutics, Inc. | OCAT | Grant | Stock Option (Right to Buy) | 500k | $0.06 | $30.8k | | 12/31/2013 |
| 12/31/2013 | Ocata Therapeutics, Inc. | OCAT | Grant | Common Stock | 125k | $0.00 | $0 | | 12/31/2013 |
| 12/30/2013 | INVIVO THERAPEUTICS HOLDINGS CORP. | NVIV | Grant | COMMON STOCK | 22.4k | $0.00 | $0 | | 12/30/2013 |
| 03/30/2011 | ImmunoGen, Inc. | IMGN | Grant | Stock option (right to buy) | 40k | $8.91 | $356.4k | | 03/30/2011 |
| 07/23/2010 | ImmunoGen, Inc. | IMGN | Grant | Stock option (right to buy) | 75k | $9.14 | $685.5k | | 07/23/2010 |